ROCK HILL, South Carolina, June 07, 2022 (GLOBE NEWSWIRE) — 3D Systems (NYSE: DDD) today announced the appointment of David J. Shulkin, MD, former U.S. Secretary of Veterans Affairs, to the Medical Advisory Board recently created by the company (MAB). MAB’s primary mission is to provide strategic information, advice and recommendations for the company’s growing efforts in regenerative medicine.
As one of the nation’s most respected experts in healthcare management, Secretary Shulkin is widely recognized as a visionary leader in patient-centered care. His passion and expertise led to his first appointment as the first Chief Medical Officer of the University of Pennsylvania Health System and then as President and CEO of Beth Israel Medical Center in New York.
As a testament to his leadership and vision, Dr. Shulkin was appointed in 2015 by President Barack Obama to serve as Undersecretary of Veterans Affairs for Health at the United States Department of Veterans Affairs (VA). Recognizing Dr. Shulkin’s leadership abilities, he was nominated in 2017 by President Donald Trump to become the ninth U.S. Secretary of Veterans Affairs. He was confirmed by the Senate 100-0, becoming the highest ranking government official to serve under Presidents Obama and Trump. During his tenure, Secretary Shulkin worked to transform and modernize the VA healthcare system, the government’s second-largest organization with more than 350,000 employees and 1,700 facilities nationwide. Since leaving the VA, Secretary Shulkin has continued his distinguished career as a leading advocate for patient-centered care and the continued transformation of health care to improve quality and accessibility for all. in need. He is the author of three books and the recipient of numerous awards for professional excellence, including his nomination as one of the 100 most influential leaders in healthcare by Modern healthcare.
Commenting on Dr. Shulkin’s appointment, Dr. Jeffrey Graves, President and CEO of 3D Systems, said, “We are extremely pleased with Secretary Shulkin’s willingness to join our new Medical Advisory Board. His vast experience and expertise will be invaluable in guiding our efforts, not only in the burgeoning field of regenerative medicine, but also in the further expansion of our existing Healthcare Solutions business, which primarily focuses on applications dental and orthopedic for 3D printing. .”
In recognition of his appointment, Secretary Shulkin said, “3D Systems is a recognized leader in applying 3D printing technology to address some of the most challenging areas of medicine today. The capability offered by their technology for mass customization of patient-specific solutions, ranging from orthopedic indications to the emerging field of regenerative medicine, is truly exceptional. I am honored and delighted to be an advisor to the company as it continues to progress in all of these areas. »
Forward-looking statements
Certain statements made in this release that are not statements of historical or current fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors. which may cause the company’s actual results, performance or achievements to be materially different from historical results or any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by words such as “believes”, “believes”, “expects”, “may”, “will”, “estimates”, “intends”. , “anticipate” or “plan” or the negative of these terms or other comparable terms. Forward-looking statements are based on management’s current beliefs, assumptions and expectations and may include comments about the company’s beliefs and expectations regarding future events and trends affecting its business and are necessarily subject to uncertainties, including many are beyond the company’s control. The factors described under the headings “Forward-Looking Statements” and “Risk Factors” in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or anticipated in the forward-looking statements. research statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, the forward-looking statements are not and should not be taken as guarantees of future performance or results, and they will not necessarily prove to be precise indications. the times at which these performances or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by or on behalf of management, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law. requires it.
About 3D Systems
Over 30 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance and reliability to every interaction – enabling our customers to create products and business models never before possible. Through our unique offering of hardware, software, materials and services, each application-specific solution is powered by the expertise of our application engineers who work with customers to transform the way they deliver their products and services. 3D Systems’ solutions serve a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace and defense, automotive, and durable goods. More information about the company is available at www.3dsystems.com.
Contact with investors: investor.relations@3dsystems.com
Media contact: press@3dsystems.com
